Clinical Trials

240 enrolled

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT06646614 2026-01-28

Group Advanced Care Planning Pilot for Veterans

50 enrolled

Tumor-Agnostic

Neoplasms

NCT05179408 2026-01-27

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

40 enrolled

Lung Neoplasms

NCT05467748 2026-01-27

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

66 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07351019 2026-01-20

Colonoscopy Bowel Prep Comparison Among Diabetic Patients

80 enrolled

Colon Cancer Screening

NCT05926102 2026-01-13

ProGRESS

5,000 enrolled

Genetic Risk Score, Prostatic Neoplasms

NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

60 enrolled

Prostatic Neoplasms

NCT06778434 2025-12-22

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

48 enrolled

Dermatologic

Keratosis, Actinic

NCT06671613 2025-11-10

Stage IV NSCLC

66 enrolled

Carcinoma, Non-Small-Cell Lung, Fasting

NCT05563766 2025-11-05

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

78 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT06574009 2025-11-03

Better Options for Chronic Cancer Pain

294 enrolled

Opioid-Related Disorders, Chronic Pain

NCT05994482 2025-10-16

SOA

Recruiting

130,000 enrolled

Colorectal Neoplasms

NCT06520098 2025-10-14

Benefit VA

LymphoidOther hematologic neoplasm

100 enrolled

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06432985 2025-09-30

CM_TUD_Cancer

108 enrolled

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

NCT05486572 2025-09-26

PREMIUM

4,700 enrolled

Chronic Disease, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT05519241 2025-09-02

A Phase I Intravesical PPM Therapy for NMIBC

Phase 1 Recruiting

29 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04038502 2025-08-20

COBRA

Classical hematologyGenitourinary

100 enrolled

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT06825715 2025-08-01

MIPO

2,653 enrolled

Advanced Cancers of the Prostate

NCT07019844 2025-07-23

PSMA PET for the Staging and Management of Hepatocellular Carcinoma

Recruiting

90 enrolled

Carcinoma, Hepatocellular

NCT07058571 2025-07-10

Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention

Other hematologic neoplasm

30 enrolled

Motor Activity, Hematologic Neoplasms

NCT05011383 2025-07-09

VA-BAT

51 enrolled

Prostatic Neoplasms

NCT06746623 2025-06-05

Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux

400 enrolled

Barrett Esophagus, Tobacco Use

NCT05912257 2025-05-28

NOSH

188 enrolled

Tumor-Agnostic

Neoplasms

NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

15 enrolled

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT06252662 2024-11-19

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

200 enrolled

Breast

Breast Neoplasms, Pain, Postoperative

NCT05430009 2022-08-01

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Phase 1 Recruiting

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03753243 2022-04-20

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

32 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04018872 2021-11-04

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

78 enrolled